HFA Premium Access

Late breaking trial II - Chronic heart failure

Event: Heart Failure 2018 & World Congress on Acute Heart Failure
Topic: Chronic Heart Failure
Session type: Special Session
Date: 27 May 2018
Time: 08:30 - 10:00

Session

12 presentations in this session

The HF-Wii study: Improving exercise capacity of patients with heart failure through exergaming: Secondary outcomes and per protocol analysis of an international multicenter RCT

Speaker: Professor T. Jaarsma (Linkoping, SE)
Thumbnail

Discussion - HF-Wii

Thumbnail

Diabetes and obesity in heart failure: a crossroads for prognosis and the efficacy of beta-blockers

Speaker: Professor D. Kotecha (Birmingham, GB)
Thumbnail

Discussion - BB-meta-HF

Thumbnail

Phase ii trial of pharmacogenetic guided beta-blocker therapy with bucindolol vs. metoprolol for the prevention of atrial fibrillation/flutter in heart failure: GENETIC-AF

Speaker: Professor W. Abraham (Columbus, US)
Thumbnail

Discussion - GENETIC-AF

Thumbnail

Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure and a left ventricular assist device

Speaker: Doctor A. Lyon (London, GB)
Thumbnail

Discussion - SERCA-LVAD TRIAL

Thumbnail

Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort

Speaker: Associate Professor G. Savarese (Stockholm, SE)
Thumbnail

Discussion - RASi in elderly patients with HFrEF

Thumbnail

6 speakers from this session

Professor Tiny Jaarsma

Linkoping University, Linkoping (Sweden)
27 presentations
1 follower

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
26 presentations
0 follower

Professor William Abraham

The Ohio State University, Columbus (United States of America)
37 presentations
0 follower

Doctor Alexander Lyon

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
30 presentations
3 followers

Associate Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)
16 presentations
0 follower

Professor Michel Komajda

Groupe Hospitalier Paris Saint-Joseph, Paris (France)
31 presentations
0 follower

This platform is supported by

logo Novo Nordisk